Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Mary Quin appointed as CEO of Callaghan Innovation

Mary Quin appointed as CEO of Callaghan Innovation

Callaghan Innovation announces the appointment of Dr Mary Quin, an exceptional New Zealander with an impressive track record of working in the US engineering and technology sector, as the inaugural CEO of Callaghan Innovation.

With a background in R&D in materials engineering and over 20 years’ experience working in senior executive roles in NASDAQ-listed companies such as Xerox and Eastman Kodak Company, Dr Quin comes with an impressive profile and experience in technology and engineering industries.

“We are delighted to have a person of Mary Quin’s calibre to lead Callaghan Innovation. With her knowledge of industry and her business acumen, we believe that she can drive substantial commercialisation opportunities for Callaghan Innovation and for New Zealand companies,” says Callaghan Innovation chair Sue Suckling.

“During her most recent tenure at the 2,800-person US support services company, NANA Management Services LLC, where she has been President for the last seven years, she has more than doubled revenues to US$200 million through value creation and diversification. NMS is jointly owned by indigenous Inupiat people of Alaska with whom Mary has worked closely and successfully over a number of years.

“This is the kind of leadership and vision that will propel Callaghan Innovation and its clients forward as we strengthen and grow New Zealand’s science, engineering, design and technology capability and its commercial presence,” says Suckling.

“Her international experience will also be invaluable as a key goal of the organisation is to grow and scale New Zealand’s innovation and sell it to world markets,” says Suckling.
Palmerston North-born Dr Quin has a distinguished academic background. After graduating from the University of Canterbury with a Bachelor of Science (Honours) with first class honours in Physics, she completed a PhD in Materials Science and Engineering at Northwestern University in Illinois. After working in research and development for engineering company Raychem for several years, she attended Harvard Business School, where she graduated as a Baker Scholar, the highest distinction given for the top 5% of MBA graduates.

Dr Quin is also an international bestselling author. Her book, Kidnapped in Yemen, draws on her personal experience of being kidnapped as part of a small tour group over Christmas in 1998 in Yemen.

“The creation of Callaghan Innovation has launched exciting new possibilities for generating commercial value from Kiwi ingenuity, science, technology and ideas. I am delighted to be joining not only the talented research, engineering and investment teams already at Callaghan Innovation but also New Zealand’s network of businesses, investors, and educational, research and government institutions, as we tackle our challenging new mission together,” says Dr Quin.

Dr Quin will relocate from Anchorage, Alaska and will be based in Wellington but will spend a significant amount of her time working in Auckland. She will begin her new role as CEO of Callaghan Innovation on May 3, 2013. Her main responsibilities will include ensuring that Callaghan Innovation accelerates the commercialisation of innovation of New Zealand firms in order to strengthen export capability and grow New Zealand’s economy.

Mary Quin

Dr Quin was most recently President of support services company NANA Management Services LLC, in Anchorage Alaska. With revenues of US$200M, Quin has expanded the company’s operations to 16 states in the US and has more than doubled revenues. She was also the founder and CEO of retail trade company Tuliqi LLC in Alaska. During her five years at Xerox Corporation (1995-2000), Dr Quin held Vice-President and GM roles in various business units. At Xerox, she drove collaboration across both divisional and national boundaries to develop technology strategies that became a key platform for Xerox’s long-term growth. While at Eastman Kodak (1988-93), she worked in both marketing and sales and managed the US$600M Mid-Volume Copier and Printer business for the company’s Office Imaging Division.


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Royal Society: Review Finds Community Water Fluoridation Safe And Effective

A review of the scientific evidence for and against the efficacy and safety of fluoridation of public water supplies has found that the levels of fluoridation used in New Zealand create no health risks and provide protection against tooth decay. More>>

ALSO:

Scoop Business: Croxley Calls Time On NZ Production In Face Of Cheap Imports

Croxley Stationery, whose stationery brands include Olympic, Warwick and Collins, plans to cease manufacturing in New Zealand because it has struggled to compete with lower-cost imports in a market where the printed word is giving way to electronic communications. More>>

ALSO:

Prefu Roundup: Forecasts Revised, Surplus Intact

The National government heads into the election with its Budget surplus target broadly intact, delivering a set of economic and fiscal forecasts marginally revised from May to reflect weaker commodity prices and a lower tax take. More>>

ALSO:

Convention Centre: Major New SkyCity Hotel And Laneway For Auckland

Today SKYCITY Entertainment Group Limited revealed plans to build a new hotel and pedestrian laneway of bars, restaurants and boutique shopping on land it owns in the Nelson and Hobson Streets block, expanding the SKYCITY Entertainment Precinct. More>>

ALSO:

Igniting The Spark: Bringing The Digital Enabler To Life

Changing a name is, relatively speaking, the easy part of a re-invention. Changing a culture, getting all the ducks in a row, turning yourself inside-out to become customer-inspired is a much bigger challenge. More>>

ALSO:

Ebola And NZ: Targeted Screening At Airport But Risk Low

The risk of any cases of Ebola in New Zealand remains very low, but health and border authorities are well prepared... anyone arriving in New Zealand who in the last three weeks has visited countries affected will be screened for symptoms of the disease. More>>

ALSO:

Scoop Business: Brewer Seeking Crowd-Funding Cancels Shareholders’ Dividends

Shareholders in Renaissance Brewing company, the first business to seek equity through crowd-funding in New Zealand, have cancelled their claim on $147,000 of accumulated earnings “to make Renaissance a more attractive investment opportunity.” More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news